Stock TAK TAKEDA PHARMACEUTICAL COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Takeda Pharmaceutical Company Limited Nyse

Equities

TAK

US8740602052

Pharmaceuticals

Real-time Estimate Cboe BZX
Other stock markets
 20:17:45 23/05/2024 BST 		5-day change 1st Jan Change
13.02 USD -0.34% Intraday chart for Takeda Pharmaceutical Company Limited -2.29% -8.86%
05-16 Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment MT
05-15 Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification MT

Business Summary

Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized around 2 areas:

- sale of drugs and consumer care products;

- services.

Net sales are distributed geographically as follows: Japan (17.5%), Asia (5%), the United States (49%), Europe and Canada (20.8%), Latin America (3.8%), Russia and CIS (1.8%) and other (2.1%).

Number of employees: 49,095

Sales per Business

JPY in Million2022Weight2023Weight Delta
Gastrointestinal
27.2 %
875,685 24.5 % 1,094,541 27.2 % +24.99%
Plasma Derivatives (Immune)
16.8 %
506,951 14.2 % 678,443 16.8 % +33.83%
Neuroscience
15.8 %
482,294 13.5 % 637,711 15.8 % +32.22%
Other
11.3 %
624,150 17.5 % 454,598 11.3 % -27.17%
Oncology
10.9 %
468,730 13.1 % 438,742 10.9 % -6.40%
Rare Genetic Disease and Others
10.4 %
- - 418,724 10.4 % -
Rare Hematology
7.6 %
283,689 7.9 % 304,718 7.6 % +7.41%

Sales per region

JPY in Million2022Weight2023Weight Delta
United States
52.2 %
1,714,421 48.0 % 2,103,772 52.2 % +22.71%
Europe and Canada
20.9 %
739,168 20.7 % 842,668 20.9 % +14.00%
Japan
12.7 %
658,983 18.5 % 512,043 12.7 % -22.30%
Asia
5.6 %
196,964 5.5 % 225,007 5.6 % +14.24%
Latin America
4.0 %
128,467 3.6 % 160,375 4.0 % +24.84%
Other
2.4 %
68,945 1.9 % 95,182 2.4 % +38.05%
Russia / Commonwealth of Independent States
2.2 %
62,057 1.7 % 88,431 2.2 % +42.50%

Managers

Managers TitleAgeSince
Christophe Weber CEO
 Chief Executive Officer 57 31/03/14
Gabriele Ricci CTO
 Chief Tech/Sci/R&D Officer 45 31/01/22
Mwana Lugogo CMP
 Compliance Officer 54 31/12/11
Michael Mendelsohn CTO
 Chief Tech/Sci/R&D Officer 69 31/03/15
Andrew Plump CTO
 Chief Tech/Sci/R&D Officer 58 31/01/15
Norimasa Takeda CMP
 Compliance Officer - -
Constantine Saroukos BRD
 Director/Board Member 53 31/12/14
Haruhiko Hirate IRO
 Public Communications Contact - -
Takashi Okubo IRO
 Public Communications Contact - -
Christopher O'Reilly IRC
 Investor Relations Contact - 31/05/11

Members of the board

Members of the board TitleAgeSince
Yoshiaki Fujimori BRD
 Director/Board Member 71 31/05/16
Ian Clark BRD
 Director/Board Member 62 31/12/18
Steven Gillis BRD
 Director/Board Member 71 31/12/18
John Maraganore BRD
 Director/Board Member 60 31/05/22
Emiko Higashi BRD
 Director/Board Member 64 31/05/16
Koji Hatsukawa BRD
 Director/Board Member 72 31/05/16
Christophe Weber CEO
 Chief Executive Officer 57 31/03/14
Andrew Plump CTO
 Chief Tech/Sci/R&D Officer 58 31/01/15
Constantine Saroukos BRD
 Director/Board Member 53 31/12/14
Kimberly Reed BRD
 Director/Board Member 53 31/05/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 1,582,418,725 1,568,419,964 ( 99.12 %) 13,405,261 ( 0.8471 %) 99.12 %

Shareholders

NameEquities%Valuation
BlackRock Fund Advisors
3.496 %
55,319,129 3.496 % 1 460 M $
BlackRock Japan Co. Ltd.
2.276 %
36,020,800 2.276 % 951 M $
Nikko Asset Management Co., Ltd.
2.194 %
34,711,100 2.194 % 916 M $
Nippon Life Insurance Co.
1.564 %
24,752,000 1.564 % 653 M $
Takeda Science Foundation
1.132 %
17,912,000 1.132 % 473 M $
TAKEDA PHARMACEUTICAL COMPANY LIMITED
0.4747 %
7,511,300 0.4747 % 198 M $
BlackRock Investment Management (UK) Ltd.
0.3774 %
5,972,275 0.3774 % 158 M $
BlackRock (Netherlands) BV
0.2850 %
4,509,380 0.2850 % 119 M $
Takeda Pharmaceutical Employee Incentive Plan
0.2294 %
3,630,339 0.2294 % 96 M $
Sumitomo Mitsui Trust Asset Management Co., Ltd.
0.1929 %
3,052,899 0.1929 % 81 M $
NameEquities%Valuation
Nikko Asset Management Co., Ltd.
2.762 %
87,400,834 2.762 % 1 142 M $
Capital Research & Management Co. (Global Investors)
0.4146 %
13,121,930 0.4146 % 172 M $
Mondrian Investment Partners Ltd.
0.3817 %
12,079,962 0.3817 % 158 M $
Eaton Vance Management
0.1578 %
4,995,623 0.1578 % 65 M $
The Ayco Co. LP
0.1330 %
4,209,431 0.1330 % 55 M $
Renaissance Technologies LLC
0.0985 %
3,118,200 0.0985 % 41 M $
Brandes Investment Partners LP
0.0917 %
2,902,507 0.0917 % 38 M $
Fidelity Management & Research Co. LLC
0.0813 %
2,574,240 0.0813 % 34 M $
Wells Fargo Bank NA
0.0813 %
2,571,467 0.0813 % 34 M $
Millennium Management LLC
0.0734 %
2,322,444 0.0734 % 30 M $
NameEquities%Valuation
BB Gestão de Recursos DTVM SA
0.000100 %
1,576 0.000100 % 20 546 $

Holdings

NameEquities%Valuation
TAKEDA PHARMACEUTICAL COMPANY LIMITED
0.47%
 7,511,300 0.47% 198,229,742 $
HILLEVAX, INC.
13.53%
 6,724,000 13.53% 80,822,480 $
DENALI THERAPEUTICS INC.
2.96%
 4,214,559 2.96% 63,049,803 $
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD.
7.21%
 2,204,000 7.21% 32,619,178 $
OVID THERAPEUTICS INC.
12.42%
 8,781,996 12.42% 26,258,168 $
PHATHOM PHARMACEUTICALS, INC.
4.77%
 2,790,480 4.77% 25,393,368 $
NOILE-IMMUNE BIOTECH INC.
18.76%
 8,119,800 18.76% 8,358,928 $
WAVE LIFE SCIENCES LTD.
0.90%
 1,096,892 0.90% 5,199,268 $

Company contact information

Takeda Pharmaceutical Co., Ltd.

4-1-1 Dosho-machi Chuo-Ku

540-8645, Osaka

+81 3 3278 2111

http://www.takeda.co.jp
address Takeda Pharmaceutical Company Limited(TAK)

Group companies

NameCategory and Sector
Shire Biotech India Pvt Ltd.
Takeda Belgium NV
Logo Takeda Belgium NV

Takeda Belgium NV

Medical DistributorsDistribution Services

Founded in 1835, Takeda Belgium NV is a subsidiary of Takeda Pharmaceutical Co., Ltd. The company is based in Zaventem, Belgium and focuses on providing better healthcare solutions for their patients. Takeda Belgium's mission is centered around the question of how they can do more for their patients.

Medical Distributors
Takeda Pharmaceuticals U.S.A., Inc.
Logo Takeda Pharmaceuticals U.S.A., Inc.

Takeda Pharmaceuticals U.S.A., Inc.

Pharmaceuticals: MajorHealth Technology

Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.

Pharmaceuticals: Major
Shire Ireland Finance Trading Ltd.
Shire Biotech UK Holdings Ltd.
Logo Shire Biotech UK Holdings Ltd.

Shire Biotech UK Holdings Ltd.

Financial ConglomeratesFinance

Part of Takeda Pharmaceutical Co., Ltd., Shire Biotech UK Holdings Ltd. is an investment holding company. Shire Biotech UK Holdings Ltd. is based in London, UK. Founded in 2017, Shire Biotech UK Holdings functions as an investment holding company.

Financial Conglomerates
Takeda A/S
Logo Takeda A/S

Takeda A/S

Financial ConglomeratesFinance

Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.

Financial Conglomerates
Takeda Pharmaceuticals International AG
Logo Takeda Pharmaceuticals International AG

Takeda Pharmaceuticals International AG

Pharmaceuticals: MajorHealth Technology

Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland.

Pharmaceuticals: Major
Takeda Manufacturing Austria AG
Logo Takeda Manufacturing Austria AG

Takeda Manufacturing Austria AG

Pharmaceuticals: MajorHealth Technology

Part of Takeda Pharmaceutical Co., Ltd., Takeda Manufacturing Austria AG manufactures and supplies vital medicines and medical devices. The company is based in Vienna, Austria.

Pharmaceuticals: Major
Takeda GmbH
Logo Takeda GmbH

Takeda GmbH

Pharmaceuticals: MajorHealth Technology

Part of Takeda Pharmaceutical Co., Ltd., Takeda GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Konstanz, Germany. The CEOs are Wolfgang Eck, Uwe Hoffmeister, Roland Kurney. The company was founded in 1873.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Takeda Pharmaceutical Company Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
4,134 JPY
Average target price
4,762 JPY
Spread / Average Target
+15.20%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.20% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.28% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.62% 369B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.07% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.53% 282B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 244B
NOVARTIS AG Stock Novartis AG
+9.31% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-5.07% 205B
PFIZER, INC. Stock Pfizer, Inc.
-0.26% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4502 Stock
  4. TAK Stock
  5. Company Takeda Pharmaceutical Company Limited